search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Radiology


people hear the word ‘AI’ and worry about hallucinations. In medical imaging, you cannot have an AI system inventing pathology that isn’t there or removing something clinically important. In addition, you can have a brilliant algorithm, but adoption will be difficult if it disrupts the radiographers’ workflow, doesn’t integrate with existing imaging systems, or creates additional work for clinicians. “That’s also why our technology is fundamentally different from AI systems that just create an image. The output is grounded in the information acquired from the patient and in the physics of MRI. But the technical design alone is not enough; you need broader independent radiologist assessment.” She reports that GenScan AI has now


secured several LOIs/endorsements across UK, US, Kenya, and Nigeria – including the following UK collaborators: 1. Buckinghamshire Healthcare NHS Trust 2. Oxford Clinical Artificial Intelligence Research (OxCAIR)


3. Mid and South Essex NHS Foundation Trust 4. NHS InSites Programme, a national, peer-led innovation network of 18 NHS Trusts designed to test, evaluate and scale healthcare innovations in real-world NHS settings.


GenScan AI is also part of the NHS Clinical Entrepreneur Programme (NHS CEP), an award- winning NHS England programme supporting healthcare innovators to develop and scale innovations for NHS adoption. The next phase of development involves


Mary-Brenda receiving the Entrepreneurs’ Award for Social Innovation 2026


broader independent clinical validation, which will also support regulatory clearance, with initial deployments targeted for 2027.


Recognition The technology is now gaining increasing recognition for innovation and has received a number of awards. The Company of Entrepreneurs Trust recently announced GenScan AI as the winner of the Entrepreneurs’ Award for Social Innovation 2026. Through the award, the Company of Entrepreneurs Trust supports entrepreneurs whose innovations have the potential to deliver meaningful positive social impact. Alongside financial support, the programme draws on the


considerable experience, expertise and networks of members of the Worshipful Company of Entrepreneurs, giving finalists access to practical guidance and connections that can help promising ventures progress. “Winning the Entrepreneurs Award for Social


Innovation was incredibly meaningful because it recognises something that’s fundamental to why I’m building GenScan AI. I want to build a very large commercially successful technology company, but I don’t think commercial success and social impact have to be competing objectives. My goal is to build a ‘social unicorn’ – a billion-dollar company that improves billions of lives around the world. The judges said that GenScan AI is exactly the kind of innovation that the award was created to support and described it as ‘commercially ambitious, technologically advanced and capable of delivering meaningful social impact’,” Mary-Brenda reported. In Q4 2025, it was also the sole recipient of the


Founderland Forward Grant for entrepreneurs in Europe and UK building solutions with “potential for outsized impact”. Mary-Brenda has also made history as the first female and youngest winner of the Nigeria Prize for Science & Innovation, worth US$100,000. She was unanimously selected by a panel of judges, led by Dr. Omobola Johnson, making GenMRI only the 12th winning work in the Prize’s 22-year history. Following this achievement, the Nigerian Federal Government, through Dr. Tunji Alausa, Honourable Minister of Education and a medical doctor, has expressed support for a national clinical pilot involving teaching hospitals and Federal Medical Centres across Nigeria’s six geopolitical zones.


WWW.TROJANBINS.COM 01684 295782 sales@trojanbins.com Approved Supplier NHS Supply Chain 2024/S000-025534 & NHS Scotland NP851/26 Framework Agreements


November 2026 I www.clinicalservicesjournal.com 29


t


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71